<DOC>
	<DOCNO>NCT02891837</DOCNO>
	<brief_summary>The purpose study determine whether L-citrulline effective safe prevention clinical sequela Acute Lung Injury pediatric subject undergo surgery congenital heart defect .</brief_summary>
	<brief_title>L-citrulline Prevention Sequelae Acute Lung Injury Pediatrics Undergoing Cardiopulmonary Bypass Heart Defects</brief_title>
	<detailed_description>This randomize , double-blind , placebo control , multicenter study compare efficacy safety L-citrulline versus placebo subject undergo surgery congenital heart defect . Eligible subject undergo repair large unrestrictive ventricular septal defect ( VSD ) , partial complete atrioventricular septal defect ( AVSD ) , ostium primum atrial septal defect ( primum ASD ) eligible enrollment study . Each enrol subject randomize receive either L-citrulline placebo throughout administration study . Subjects receive L-citrulline bolus 150 mg/kg placebo initiation cardiopulmonary bypass , addition L-citrulline concentration 200 μmol/L placebo give bolus bypass . This may administer one-time bolus multiple administration compensate fluid contain L-citrulline may remove patient course operation thus maintain concentration 200 μmol/L . L-citrulline bolus 20 mg/kg placebo 30 minute decannulation cardiopulmonary bypass , follow immediately 9 mg/kg/hr continuous L-citrulline infusion placebo 48 hour . The study drug placebo infusion discontinue invasive arterial blood pressure monitor discontinue 48 hour , whichever come first . Subjects follow Day 28 discharge hospital , whichever come first . For subject discharge prior Day 28 , final assessment via telephone conduct Day 28 .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Lung Injury</mesh_term>
	<criteria>Subjects , parent , legal guardian subject willing able sign inform consent Male female subject age ≤18 year age Infants , child adolescent undergo CPB repair large unrestrictive VSD , ostium primum ASD , partial complete AVSD Preoperative echocardiogram confirm cardiovascular anatomy defect surgically repair Evidence pulmonary artery vein abnormality preoperative echocardiogram address surgically . Specific abnormality exclude include follow : Significant pulmonary artery narrow amenable surgical correction Previous pulmonary artery stent placement Significant leave sided AV valve regurgitation Pulmonary venous return abnormality amenable surgical correction Pulmonary vein stenosis amenable surgical correction Preoperative requirement mechanical ventilation intravenous inotrope support Presence fix idiopathic pulmonary hypertension ( i.e . Eisenmenger 's Syndrome ) prior surgical repair Preoperative use medication treat pulmonary hypertension Pregnancy ; Females childbearing potential must willing participate acceptable method birth control duration study participation ( e.g . oral contraceptive , hormonal implant , intrauterine device ) Any condition , opinion investigator , might interfere study objective Participation another clinical trial within 30 day Screening participate current study , include 28 day followup post study drug administration</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>L-citrulline</keyword>
	<keyword>pediatric</keyword>
	<keyword>Lung Injury</keyword>
	<keyword>Bypass</keyword>
	<keyword>Heart Defects</keyword>
	<keyword>Clinical Sequelae</keyword>
</DOC>